Lilly Quezada's questions to AtriCure Inc (ATRC) leadership • Q2 2025
Question
Lilly Quezada of JPMorgan Chase & Co. asked for rationale behind the updated guidance, which implies a top-line deceleration and flat-to-down EBITDA despite a strong Q2, and questioned the trends in the MIS business.
Answer
CFO Angela Wirick attributed the guidance to a consistent "beat and raise" strategy, where strong performance from new products is expected to offset increased pressure on the hybrid business. President and CEO Michael Carrel added that the strength of the broader portfolio allows the company to set conservative expectations for the MIS franchise while still delivering robust overall growth.